HOME >> BIOLOGY >> NEWS
Molecule discovered to be key to pain sensitivity

Sensitivity to pain and the risk of developing chronic pain appear to be influenced by levels of a molecule known to be required for the production of major neurotransmitters. In the November issue of Nature Medicine, an international research team based at Massachusetts General Hospital (MGH) describes this unexpected role for the molecule called BH4 and their findings that a particular set of variations in a human gene involved in synthesizing the molecule appears to reduce pain sensitivity.

"This is the first evidence of a genetic contribution to the risk of developing neuropathic pain in humans. The pain-protective gene sequence, which is carried by about 20 to 25 percent of the population, appears to be a marker both for less pain sensitivity and a reduced risk for chronic pain," says senior author Clifford Woolf, MD, PhD, director of the Neural Plasticity Research Group in the MGH Department of Anesthesia and Critical Care. "Identifying those at greater risk of developing chronic pain in response to medical procedures, trauma or diseases could lead to new preventive strategies and potential treatments."

Previous studies in animals have shown that specific strains or related groups of rodents have significant differences in their risk of developing either neuropathic pain, which results from nerve damage, or inflammatory pain, associated with the immune system's response to injuries or conditions like arthritis. But except for some rare inherited conditions, there has been no evidence that genetics contributed to the risk of neuropathic pain in humans.

The research team had previously used gene chips to find that nerve damage in rats altered the regulation of several hundred genes in associated nerve cells. They began the current study by searching through these genes to find any associated with common metabolic pathways and found that three genes that increased expression in response to nerve damage encoded enzymes involve
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
22-Oct-2006


Page: 1 2 3

Related biology news :

1. Molecule blocks gene, sheds light on liver cancer
2. Molecule that destroys bone also protects it, new research shows
3. Howard C. Berg honored with Outstanding Investigator in Single Molecule Biology Award
4. Molecules in blood foretell development of preeclampsia
5. Molecule by molecule, new assay shows real-time gene activity
6. Molecule does more than slice and dice RNA
7. Molecule links Down syndrome to Alzheimers
8. Molecule crucial for processing non-coding RNA identified
9. Molecule on immune cells linked to sexual transmission of HIV
10. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
11. Molecule that helps DNA replicate may make good target for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... OTTAWA, Ontario (PRWEB) , ... November 20, 2018 , ... ... Track-Kit system to track all newborn screening (NBS) specimens across the state. ... shipment from hospitals and delivery to the state newborn screening laboratory in Salt Lake ...
(Date:11/15/2018)... ... November 15, 2018 , ... Superior ... and IT solutions with 140 employees on both the east and west coasts, ... (CSIA) Certification. CSIA Certified control system integrators must pass an intensive audit ...
(Date:11/15/2018)... ... 14, 2018 , ... Researchers from Ambry Genetics (Ambry) ... gene-disease relationships and how it supports medical management decisions at the National Society ... , Ambry has been selected by NSGC to lead a platform presentation ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD ... by Siemens Healthineers and several healthcare VC firms announces at Distributed Health 2018 ... a history by purchasing tokens and obtaining its first radiology interpretations, one of ...
(Date:11/3/2018)... ... November 01, 2018 , ... ... Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA ... and ensure data reliability. , What should clinical research industry stakeholders keep in ...
(Date:10/31/2018)... (PRWEB) , ... October 30, 2018 , ... ... its randomized, controlled trial at the Campbell Clinic in Memphis, Tennessee. This ... system to the standard of care for managing pain after total knee replacement ...
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers Association (NCGA) announced ... competition is to find new and innovative uses of field corn. NineSigma is serving ... billion bushels of corn and are on pace to produce the second largest crop ...
Breaking Biology Technology:
Cached News: